Genetics Adviser

We’re thrilled to announce that 750 British Columbians have already tested through the #GetBRCAWise campaign! 🙏 A huge thank you to those who’ve taken this important step in caring for their health and the health of their families. 🎯 Help us reach 1,000 tests — together, we can make a difference! Did you know that up to 1 in 40 individuals with Jewish ancestry are at increased risk for certain cancers due to common BRCA gene changes? Testing for these mutations is simple, convenient, and FREE, now available to anyone with Jewish ancestry in BC and Yukon. Best of all, no referral is needed. Take charge of your health and learn more today at getBRCAwise.ca #GetBRCAWise #BRCAinBC #GeneticTesting #HealthCare #CancerPrevention #JewishAncestry #BRCA #PublicHealth #BC #Yukon

Pleased to share our Genomic Counselling Model (GCM) for supporting pre-test counselling for genome sequencing (GS) at scale through the GENCOV study, published in Genetics in Medicine. Our findings support that our GCM, which includes counselling support through group webinars and the Genetics Adviser, increases knowledge and reduces decisional conflict in participants undergoing GS from the general population. We also found that most people wanted to learn all possible types of results from GS! Full article linked below. https://lnkd.in/gJ8_D72a

See you Wednesday night! Join the Consulate General of Canada in Boston | Consulat général du Canada à Boston, Canadian Technology Accelerators | Accélerateurs technologiques canadiens and CENE as we celebrate the 2024 Boston Health+Tech CTA cohort! Meet with Boston/Cambridge biotech and health tech leaders alongside 12 exciting Canadian life sciences and tech startups covering Biotech, Medtech, Diagnostics, Digital Health and Wellness. 🗓️ Wednesday, November 20, 2024 🕔 Time: 5:00 - 8:30 PM EST 📍 Ernst & Young (200 Clarendon Street Boston, MA) 🔗Follow the link to sign up: https://lnkd.in/gqGxfwjK The event will also feature a fireside chat with CENE Board member and CTA mentor Nadine Beauger, PhD. Nadine is the Senior Director of the Therapeutic & Medical Device Accelerator at the Technology & Innovation Development Office (TIDO) of Boston Children's Hospital. She oversees and develops critical project funding initiatives as well as strategic alliances with industry partners for hospital innovations. Her leadership also extends to managing other key commercialization efforts that align with TIDO’s commitment to transforming cutting-edge research into tangible solutions for pediatric patients. 2024 Boston Health+Tech CTA cohort: Aruna Revolution | Cobionix Corporation | Genetics Adviser | Kent Imaging | MACH32 | mDETECT Inc | MedEssist💊 | Transforming Pharmacy with Tech and AI | Noa Therapeutics | RIOH inc. | SmileSonica Inc. | Triple Hair Inc. | Vesalius Cardiovascular Inc. #Canada #Biotech #DigitalHealth #Medtech #Diagnostics #Wellness Hon. Bernadette Jordan | Dina Santos | Phil Bunsick | Chris Begley | Heather Sullivan | Serban Georgescu, MD, MBA | Iraina Miles | Joshua Dillard | Anda Copilescu | Patricia Gauthier | Karla MacDonald | Rick Pierce | Scott Lewis | James De Vellis | Christopher Tan | Chris Watters | Stefano Caprara

You’re Invited! Canadian Innovation from A to Zed - Boston CTA 2024 Join the Consulate General of Canada in Boston | Consulat général du Canada à Boston, Canadian Technology Accelerators | Accélerateurs technologiques canadiens and CENE as we celebrate the 2024 Boston Health+Tech CTA cohort! Meet with Boston/Cambridge biotech and health tech leaders alongside 12 exciting Canadian life sciences and tech startups covering Biotech, Medtech, Diagnostics, Digital Health and Wellness. 🗓️ Wednesday, November 20, 2024 🕔 Time: 5:00 - 8:30 PM EST 📍 Ernst & Young (200 Clarendon Street Boston, MA) 🔗Follow the link to sign up: https://lnkd.in/gqGxfwjK The event will also feature a fireside chat with CENE Board member and CTA mentor Nadine Beauger, PhD. Nadine is the Senior Director of the Therapeutic & Medical Device Accelerator at the Technology & Innovation Development Office (TIDO) of Boston Children's Hospital. She oversees and develops critical project funding initiatives as well as strategic alliances with industry partners for hospital innovations. Her leadership also extends to managing other key commercialization efforts that align with TIDO’s commitment to transforming cutting-edge research into tangible solutions for pediatric patients. 2024 Boston Health+Tech CTA cohort: Aruna Revolution | Cobionix Corporation | Genetics Adviser | Kent Imaging | MACH32 | mDETECT Inc | MedEssist💊 | Transforming Pharmacy with Tech and AI | Noa Therapeutics | RIOH inc. | SmileSonica Inc. | Triple Hair Inc. | Vesalius Cardiovascular Inc. #Canada #Biotech #DigitalHealth #Medtech #Diagnostics #Wellness Hon. Bernadette Jordan | Dina Santos | Phil Bunsick | Chris Begley | Heather Sullivan | Serban Georgescu, MD, MBA | Iraina Miles | Joshua Dillard | Anda Copilescu | Patricia Gauthier | Karla MacDonald | Rick Pierce | Scott Lewis | James De Vellis | Christopher Tan | Chris Watters | Stefano Caprara

The Genetics Adviser team is hiring! This role is a big opportunity for someone looking to dip their toes in many areas of the business. We need someone who can be hands on and think big picture to help build towards the vision alongside the founders.